logo
  

SmartRent, Inc. Q1 Loss decreases, but misses estimates

SmartRent, Inc. (SMRT) announced Loss for first quarter that decreased from the same period last year but missed the Street estimates.

The company's bottom line came in at -$7.692 million, or -$0.04 per share. This compares with -$13.215 million, or -$0.07 per share, in last year's first quarter.

Analysts on average had expected the company to earn -$0.01 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 22.4% to $50.489 million from $65.079 million last year.

SmartRent, Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$7.692 Mln. vs. -$13.215 Mln. last year.
-EPS (Q1): -$0.04 vs. -$0.07 last year.
-Revenue (Q1): $50.489 Mln vs. $65.079 Mln last year.

-Guidance:
Next quarter revenue guidance: $49 to $55 Mln
Full year revenue guidance: $260 to $290 Mln

For comments and feedback contact: editorial@rttnews.com

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
RELATED NEWS
Follow RTT